Table 2.
Outcome of 115 Patients With Invasive Aspergillosis According to European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) and Serum Aspergillus Galactomannan Index (GMI)–Based Response Criteria
| Criteria | Success after start of antifungal therapy |
||||
| Week 3 | Week 4 | Week 5 | Week 6 | After week 6a | |
| EORTC/MSG, no. (%) of patients | NA | NA | NA | 73 (63) | 73 (63) |
| GMI-based, no. (%) of patients | 44 (38) | 65 (56) | 72 (63) | 76 (66) | 83 (72) |
| Agreement, % | … | … | … | 85 | 91b |
Abbreviations: NA, not applicable.
a
In 7 patients, the GMI normalized after the 6-week time point.
b
Agreement between the 2 response definitions was noted in all 32 nonresponders (100%) and in 73 (87%) of the 83 responders, giving an overall agreement of 91%.